Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (ToGA) : a phase 3, open-label, randomised controlled trial

収録刊行物

• Lancet

  Lancet 376 687-697, 2010